Table 2.
Model 1 outcome: 'delayed or avoided' |
Model 2 outcome: 'delayed or avoided' subgroup with chronic disease |
Model 3 outcome: 'delayed' |
Model 4 outcome: 'avoided' |
|
N | 7,198 | 3,542 | 7,198 | 7,198 |
odds ratio (95% CI) | ||||
Age (years) under 30 | 3.46 (2.72–4.39) | 3.35 (2.28–4.94) | 1.46 (1.13–1.90) | 5.44 (3.69–8.01) |
Gender male | 0.98 (0.89–1.09) | 1.13 (0.97–1.31) | 0.90 (0.80–1.00) | 1.12 (0.98–1.27) |
Per capita Income (Euro) | ||||
< 600 | 2.31 (1.98–2.70) | 2.45 (1.90–3.15) | 1.45 (1.22–1.72) | 2.20 (1.81–2.68) |
600–800 | 1.73 (1.48–2.01) | 1.81 (1.45–2.28) | 1.41 (1.19–1.67) | 1.59 (1.29–1.96) |
800–1,000 | 1.31 (1.11–1.55) | 1.46 (1.14–1.87) | 1.24 (1.03–1.49) | 1.20 (0.95–1.52) |
1,000–1,300 | 1.39 (1.19–1.63) | 1.47 (1.17–1.85) | 1.27 (1.06–1.51) | 1.29 (1.04–1.61) |
HAWa little | 1.28 (1.05–1.57) | 1.94 (1.38–2.74) | 0.68 (0.53–0.87) | 2.09 (1.66–2.63) |
SAHb very good | 1.13 (0.95–1.34) | 1.22 (0.93–1.61) | 1.17 (0.97–1.41) | 1.02 (0.81–1.29) |
Chronic disease no | 1.13 (0.99–1.28) | - | 0.84 (0.73–0.96) | 1.53 (1.30–1.80) |
Maximum co-payment 1% no | 1.77 (1.50–2.09) | 1.71 (1.43–2.04) | 1.57 (1.31–1.88) | 1.59 (1.22–2.08) |
survey spring 2006 | 1.95 (1.65–2.31) | 1.88 (1.47–2.42) | 2.56 (2.12–3.10) | 0.86 (0.69–1.07) |
c-value | 0.69 | 0.70 | 0.62 | 0.72 |
H/Lc p-value | 0.49 | 0.43 | 0.45 | 0.31 |
Pseudo R2 Nagelkerke | 0.14 | 0.13 | 0.10 | 0.15 |
Pseudo R2 McFadden | 0.08 | 0.08 | 0.03 | 0.10 |
a Health awareness, b Self assessed health, c Hosmer Lemeshow test
Comparison groups: age: over 70; gender: female; per capita income: > 1,300 Euro; HAW: strong; SAH: poor; chronic disease: yes; max. co-payment of 1%: yes; survey: spring 2004